Back to Search Start Over

Circulating B-type natriuretic peptide in women with and without recent gestational diabetes: The impact of current glucose intolerance

Authors :
Bernard Zinman
Ravi Retnakaran
Mathew Sermer
Chang Ye
Philip W. Connelly
Leanne R De Souza
Anthony J. Hanley
Source :
Clinical Endocrinology. 88:227-233
Publication Year :
2017
Publisher :
Wiley, 2017.

Abstract

Context Circulating B-type natriuretic peptide, as measured by the N-terminal fragment of its prohormone (NT-proBNP), is inversely associated with incident type 2 diabetes (T2DM) but positively related to future cardiovascular disease (CVD). Recognizing that gestational diabetes (GDM) identifies women at future risk for both T2DM and CVD, we sought to determine whether gestational glucose tolerance relates to NT-proBNP in the years after delivery. Design/Patients/Measurements Three-hundred-and-forty women underwent a glucose challenge test (GCT) and an oral glucose tolerance test (OGTT) in pregnancy, yielding 4 gestational glucose tolerance groups: GDM (n=105); gestational impaired glucose tolerance (n=59); abnormal GCT with a normal OGTT (n=98); and normal GCT with normal OGTT (n=75). At 3-years postpartum, they underwent cardiometabolic characterization (including measurement of estimated glomerular filtration rate (eGFR), adiponectin, and NT-proBNP) and repeated the OGTT, revealing 69 women with glucose intolerance (pre-diabetes/diabetes). Results At 3-years postpartum, serum NT-proBNP did not differ between the 4 original gestational glucose tolerance groups (p=0.44), but instead progressively decreased across current glucose tolerance strata, from normal to pre-diabetes to diabetes (p=0.006). Indeed, on logistic regression analysis, NT-proBNP emerged as a negative predictor of pre-diabetes/diabetes (OR=0.903, 95%CI 0.825-0.988, p=0.026). On multiple linear regression analyses of NT-proBNP, the significant association with current glucose intolerance was ultimately attenuated in a fully-adjusted model, revealing two independent determinants of NT-proBNP: eGFR (t=-2.71, p=0.007) and adiponectin (t=2.44, p=0.015). Conclusion Serum NT-proBNP relates to current glucose intolerance, rather than preceding gestational dysglycemia. Thus, the diabetic (rather than vascular) risk implications of NT-proBNP predominate in young women. This article is protected by copyright. All rights reserved.

Details

ISSN :
03000664
Volume :
88
Database :
OpenAIRE
Journal :
Clinical Endocrinology
Accession number :
edsair.doi.dedup.....3bf3e87d6233c9e4c7f9b821c2993609
Full Text :
https://doi.org/10.1111/cen.13510